Red Journal Podcast November 15, 2025: Radiation for Gray Zone, Cutaneous T-Cell, and Pediatric Hodgkin Lymphoma
Send us a textEditor-in-Chief Sue Yom co-hosts with Dr. Sarah Milgrom, Associate Professor in the Department of Radiation Oncology at the University of Colorado and Section Editor for Lymphoma, interviewing Dr. Brad Hoppe, Professor in the Department of Radiation Oncology and Medical Director of Particle Therapy from Mayo Clinic Jacksonville, who was last author on “The Role of Radiation Therapy in the Management of Grey Zone Lymphoma,” first author on “Comparison of Contemporary Radiotherapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331,” and submitting author of a striking art cover called “Set in Bloom” created by his young adult patient Katherine Beatty, a survivor of Gray Zone lymphoma, as well as Dr. Belinda Campbell, Associate Professor and Deputy Director of Radiation Oncology at Peter MacCallum Cancer Centre and first author of “Radiation therapy utilization for primary cutaneous T-cell lymphoma is lowest amongst patients living in the most geographically accessible areas; an Australian study.”
--------
1:05:42
--------
1:05:42
Red Journal Podcast ASTRO 2025: Frontiers of the Known Universe of Radiation Oncology
Send us a textFor ASTRO 2025, our Editor-in-Chief Dr. Sue Yom hosts Dr. Minesh Mehta, Chief, Deputy Director and John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute and first author of the article “Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study”; Dr. Cliff Robinson, Professor and Chief of SBRT at Washington University in St. Louis, Thoracic Section Editor, and supervising author of Stereotactic Arrhythmia Radiotherapy (STAR) vs Repeat Catheter Ablation for High-Risk Refractory Ventricular Tachycardia: 3-Year Safety and Efficacy Outcomes; and Dr. Alexa Dang, Clinical Instructor in Radiation Oncology at BC Cancer in Vancouver and first author of Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial.
--------
58:21
--------
58:21
Red Journal Podcast November 1, 2025: Where Does Hope Come From?
Send us a textEditor-in-Chief Dr. Sue Yom hosts Dr. Ben Corn, Professor of Oncology and Director of the Institute for the Study of Hope, Dignity & Wellbeing at Hebrew University School of Medicine in Jerusalem, and first author of our article published this month, ““Hope” Drives Quality of Life in Patients With Brain Metastases, But, the “Hope Center” Remains Elusive: An Analysis of NRG-CC003”; Dr. Vinai Gondi, Clinical Associate Professor and Service Line Director of Radiation Oncology in the Northwestern Medicine West Region, co-author on this paper and Principal Investigator of the parent clinical trial that enabled this study, NRG-CC003; and Dr. Tracy Balboni, Professor and Program Director of the Harvard Radiation Oncology Program, Director of Skeletal Radiation Oncology at Dana-Farber Cancer Center, Co-Director of the Initiative on Health, Spirituality, and Religion at Harvard, and the author of an accompanying editorial to this article, “Hope in Wisdom Past and for Future Clinical Trials.”
--------
1:09:01
--------
1:09:01
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline
Send us a textASTRO has recently updated guidelines for post mastectomy radiotherapy (PMRT) to align practice with outcomes from multiple newly published studies for locally advanced breast cancer published over the past decade. This podcast, led by Melissa Pulfer Mitchell, MD, features lead authors of the new ASTRO PMRT guidelines Kathleen C. Horst, MD, and Rachel B. Jimenez, MD, and highlights the main questions answered by the new guidelines, as well as limitations of this expert consensus and lingering questions to be addressed.
--------
33:02
--------
33:02
Red Journal Podcast October 1, 2025: Postprostatectomy Hypofractionation – Hold and Assess the Risks or Keep Going Further?
Send us a textDr. Sue Yom, Editor in Chief, co-hosts with Deputy Editor Dr. Alison Tree, in discussion/debate with Dr. John Floberg, Associate Professor and Director of Theranostics in the Department of Human Oncology at the University of Wisconsin and last author of “Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy”; Dr. Paul Sargos, Head of the Department of Radiotherapy at the Institut Bergonié in Bordeaux, France and last author of an accompanying editorial, ”Hypofractionated radiotherapy for prostate cancer in the postoperative setting: is it capable of going the distance?”; and Dr. Ron Chen, Professor and Chair of Radiation Oncology at the University of Kansas, an Associate Editor at the journal, and a co-chair of NRG-GU003, who was corresponding author on a counterpoint editorial, “Long Term Outcomes in Hypofractionated Post-Prostatectomy Radiation: Cautionary Tale or Expected Findings?”
Stay current with the latest studies in radiation oncology with free podcasts from the official journals of the American Society for Radiation Oncology (ASTRO). The International Journal of Radiation Oncology-Biology-Physics (the Red Journal) publishes the latest clinical research related to radiation oncology, radiation biology, medical physics, education, and health policy. The overarching mission of Practical Radiation Oncology is to improve the quality of radiation oncology practice through publication of official ASTRO guidelines and white papers, discussion and illustration of new techniques, evaluation of current practices, and publication of case reports. Advances in Radiation Oncology is a wide-ranging clinical research journal whose articles are free and open for all to read. Visit www.redjournal.org, www.practicalradonc.org, and www.advancesradonc.org to learn more about ASTRO's journals.
Österreich